Ionis Pharmaceuticals (IONS) Misses Q2 EPS by 20c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. LBRX
2. MRK
3. TRAX
4. LMT
5. FATE
6. KTOS
7. FFAI
8. IRIX
9. BRO
10. AON

Go back to Ionis Pharmaceuticals (IONS) Misses Q2 EPS by 20c, Revenues Miss

Ionis Pharmaceuticals (IONS) PT Lowered to $47 at Stifel

August 9, 2018 6:24 AM EDT

Stifel lowered its price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $47.00 (from $48.00) while maintaining a Hold rating.

... More

Stifel Transfers Coverage of Ionis Pharmaceuticals (IONS), Maintains Hold

August 6, 2018 4:19 PM EDT

Stifel assumes coverage on Ionis Pharmaceuticals (NASDAQ: IONS) with a Hold rating and a price target of $48.00.

Analyst Paul Matteis assumes coverage at Hold and lowers the PT to $48.00 (from $55.00)

For an analyst ratings summary and ratings history on Ionis Pharmaceuticals... More